Alpha blocker

Jump to navigation Jump to search

WikiDoc Resources for Alpha blocker

Articles

Most recent articles on Alpha blocker

Most cited articles on Alpha blocker

Review articles on Alpha blocker

Articles on Alpha blocker in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Alpha blocker

Images of Alpha blocker

Photos of Alpha blocker

Podcasts & MP3s on Alpha blocker

Videos on Alpha blocker

Evidence Based Medicine

Cochrane Collaboration on Alpha blocker

Bandolier on Alpha blocker

TRIP on Alpha blocker

Clinical Trials

Ongoing Trials on Alpha blocker at Clinical Trials.gov

Trial results on Alpha blocker

Clinical Trials on Alpha blocker at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Alpha blocker

NICE Guidance on Alpha blocker

NHS PRODIGY Guidance

FDA on Alpha blocker

CDC on Alpha blocker

Books

Books on Alpha blocker

News

Alpha blocker in the news

Be alerted to news on Alpha blocker

News trends on Alpha blocker

Commentary

Blogs on Alpha blocker

Definitions

Definitions of Alpha blocker

Patient Resources / Community

Patient resources on Alpha blocker

Discussion groups on Alpha blocker

Patient Handouts on Alpha blocker

Directions to Hospitals Treating Alpha blocker

Risk calculators and risk factors for Alpha blocker

Healthcare Provider Resources

Symptoms of Alpha blocker

Causes & Risk Factors for Alpha blocker

Diagnostic studies for Alpha blocker

Treatment of Alpha blocker

Continuing Medical Education (CME)

CME Programs on Alpha blocker

International

Alpha blocker en Espanol

Alpha blocker en Francais

Business

Alpha blocker in the Marketplace

Patents on Alpha blocker

Experimental / Informatics

List of terms related to Alpha blocker

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Overview

Alpha blockers (also called alpha-adrenergic blocking agents) constitute a variety of drugs which block α1-adrenergic receptors in arteries and smooth muscles.

Indications

These drugs may be used to treat:

Examples of alpha blockers

Alpha blockers include:

Tamsulosin is relatively selective for α1a-adrenergic receptors, which are mainly present in the prostate. Hence, it may have a more selective action in BPH with minimal effects on blood pressure.

Adverse effects and interactions

By reducing α1-adrenergic activity of the blood vessels, these drugs may cause hypotension (low blood pressure) and interrupt the baroreflex response. In doing so, they may cause dizziness, lightheadedness, or fainting when rising from a lying or sitting posture (known as orthostatic hypotension or postural hypotension). For this reason, it is generally recommended that alpha blockers should be taken at bedtime. Additionally, the risk of orthostatic hypotension may be reduced by starting at a low dose and titrating upwards as needed.

Because these medications may cause orthostatic hypotension, as well as hypotension in general, these agents may interact with other medications that increase risk for hypotension, such as other antihypertensives and vasodilators.

As discussed above, tamsulosin may have less risk for hypotension and orthostatic hypotension due to its selectivity for α1a-adrenergic receptors. On the other hand, the drug:

(a) elevates risk for floppy iris syndrome,

(b) might show ADRs characteristic of the sulfa related drugs.

References


Template:Receptor agonists and antagonists

de:Alphablocker it:Alfa bloccante


Template:WikiDoc Sources